Athersys may be close to commercializing stem cell therapy in Japan, new CEO says

March 18, 2022 Editor

← Parent company of KC bank removes chairman who expressed ‘profound disappointment’ in leadership
Oyo rejigs top brass ahead of IPO, replaces CEO of India business →